Physician profile
John M Galla
NPI 1881743607
$81,521.00
in general payments reported to CMS, 2019-2025
29 companies · $1,691 in 2025
The $1,691 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $1,440 · 2021: $6,768 · 2022: $8,743 · 2023: $9,001 · 2024: $16K · 2025: $1,691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Food and Beverage: $4,067 · Travel and Lodging: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,080.00 |
| Food and Beverage | $4,067.06 |
| Travel and Lodging | $615.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $73,619.90 | 2019-2024 | Xarelto |
| Medtronic, INC. | $1,953.45 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Boston Scientific Corporation | $1,259.87 | 2019-2025 | Eluvia, Baylis Medical Company Radiofrequency Puncture Generator |
| Abbott Laboratories | $1,248.09 | 2019-2024 | Navitor, Jeti, Mitraclip |
| Philips North America LLC | $1,053.58 | 2019-2025 | Labosys, (Az7) Lasers |
| Medtronic Vascular, INC. | $687.67 | 2019-2020 | |
| Edwards Lifesciences Corporation | $271.54 | 2020-2024 | Sapien 3 Ultra Resilia |
| Penumbra, INC. | $192.22 | 2023-2025 | Indigo System, Penumbra System |
| Shockwave Medical, INC | $180.72 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Scientific Affairs, LLC | $149.99 | 2023 | Xarelto |
| Biotronik INC. | $114.61 | 2022 | |
| Abiomed | $103.05 | 2020-2025 | |
| Contego Medical, INC | $92.33 | 2024 | |
| Cardiovascular Systems INC. | $89.96 | 2019 | |
| Bard Peripheral Vascular, INC. | $81.32 | 2025 | Rotarexs 6 F X 135 Cm |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $67.01 | 2025 | Camzyos |
| Veryan Medical Incorporated | $57.49 | 2022 | |
| Novartis Pharmaceuticals Corporation | $54.61 | 2022-2024 | |
| Baxter Healthcare | $43.68 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.97 | 2021-2023 | Jardiance |
| Pfizer INC. | $35.25 | 2023-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $21.30 | 2024 | Arcalyst |
| Terumo Medical Corporation | $20.28 | 2022 | |
| Amgen INC. | $18.39 | 2019 | |
| Merck Sharp & Dohme LLC | $16.95 | 2025 | Verquvo |
| Inspiremd LTD | $16.40 | 2025 | Cguard Prime Carotid Stent System |
| Esperion Therapeutics, INC. | $15.88 | 2021 | |
| Reflow Medical INC | $15.49 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Galla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.